As the Director for HPTN, Nirupama Sista, MSc, PhD leads the development and implementation of all ongoing HPTN research studies. She also focuses on strategic partnerships with funding agencies and collaborative partners. Dr. Sista is a senior research scientist at FHI 360 with more than 20 years of experience in the academic, pharmaceutical and non-profit sectors. Before joining FHI 360 Dr. Sista was a Senior Clinical Research Scientist for Triangle Pharmaceuticals, now Gilead Sciences. She earned her PhD in microbiology from the University of Tennessee, with post-doctoral training at the University of North Carolina at Chapel Hill.